MicroRNAs in the Pathogenesis, Diagnosis, and Treatment of Liver Disease

B. B. Madison, T. A. Kerr

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Posttranscriptional regulation of gene expression is now recognized as an important contributor to disease pathogenesis, occurring by mechanisms that alter the function, stability, and translation of RNAs via cis-elements within both coding and noncoding regions of messenger RNAs (mRNAs). A major component in this regulatory paradigm is the binding to RNA-stabilization and translational control elements by microRNAs (miRNAs), frequently in the 3(hermitian conjugative matrix) untranslated region of target mRNA. miRNAs are noncoding endogenously transcribed RNAs that undergo a well-characterized series of processing steps that generate short single-stranded (20-22. nt) RNA fragments that bind to complementary regions within a range of targets and inhibit translation, but primarily trigger mRNA degradation. This chapter will highlight selected advances in the role of miRNAs in liver disease including nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma and will briefly discuss the utility of miRNAs as biomarkers of liver injury and neoplasia, and how targeting or replenishing miRNAs may provide powerful and effective treatments for these diseases.

Original languageEnglish (US)
Title of host publicationTranslating MicroRNAs to the Clinic
PublisherElsevier Inc.
Pages55-92
Number of pages38
ISBN (Print)9780128005538
DOIs
StatePublished - Sep 29 2016

Fingerprint

MicroRNAs
Liver
Liver Diseases
RNA
RNA Stability
Messenger RNA
Untranslated Regions
Gene Expression Regulation
Biomarkers
Gene expression
Hepatitis
Hepatocellular Carcinoma
Stabilization
Degradation
Wounds and Injuries
Processing
Neoplasms

Keywords

  • Bioinformatics
  • Biomarker
  • Cancer
  • Hepatitis
  • Hepatocellular
  • Hepatoma
  • Liver
  • Liver injury
  • Microarray
  • MicroRNA
  • Nonalcoholic fatty liver disease
  • Nonalcoholic steatohepatitis
  • Steatosis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Madison, B. B., & Kerr, T. A. (2016). MicroRNAs in the Pathogenesis, Diagnosis, and Treatment of Liver Disease. In Translating MicroRNAs to the Clinic (pp. 55-92). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800553-8.00004-4

MicroRNAs in the Pathogenesis, Diagnosis, and Treatment of Liver Disease. / Madison, B. B.; Kerr, T. A.

Translating MicroRNAs to the Clinic. Elsevier Inc., 2016. p. 55-92.

Research output: Chapter in Book/Report/Conference proceedingChapter

Madison, B. B. ; Kerr, T. A. / MicroRNAs in the Pathogenesis, Diagnosis, and Treatment of Liver Disease. Translating MicroRNAs to the Clinic. Elsevier Inc., 2016. pp. 55-92
@inbook{c5584c5f71a84534ae8f8324863dc93f,
title = "MicroRNAs in the Pathogenesis, Diagnosis, and Treatment of Liver Disease",
abstract = "Posttranscriptional regulation of gene expression is now recognized as an important contributor to disease pathogenesis, occurring by mechanisms that alter the function, stability, and translation of RNAs via cis-elements within both coding and noncoding regions of messenger RNAs (mRNAs). A major component in this regulatory paradigm is the binding to RNA-stabilization and translational control elements by microRNAs (miRNAs), frequently in the 3(hermitian conjugative matrix) untranslated region of target mRNA. miRNAs are noncoding endogenously transcribed RNAs that undergo a well-characterized series of processing steps that generate short single-stranded (20-22. nt) RNA fragments that bind to complementary regions within a range of targets and inhibit translation, but primarily trigger mRNA degradation. This chapter will highlight selected advances in the role of miRNAs in liver disease including nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma and will briefly discuss the utility of miRNAs as biomarkers of liver injury and neoplasia, and how targeting or replenishing miRNAs may provide powerful and effective treatments for these diseases.",
keywords = "Bioinformatics, Biomarker, Cancer, Hepatitis, Hepatocellular, Hepatoma, Liver, Liver injury, Microarray, MicroRNA, Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Steatosis",
author = "Madison, {B. B.} and Kerr, {T. A.}",
year = "2016",
month = "9",
day = "29",
doi = "10.1016/B978-0-12-800553-8.00004-4",
language = "English (US)",
isbn = "9780128005538",
pages = "55--92",
booktitle = "Translating MicroRNAs to the Clinic",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - MicroRNAs in the Pathogenesis, Diagnosis, and Treatment of Liver Disease

AU - Madison, B. B.

AU - Kerr, T. A.

PY - 2016/9/29

Y1 - 2016/9/29

N2 - Posttranscriptional regulation of gene expression is now recognized as an important contributor to disease pathogenesis, occurring by mechanisms that alter the function, stability, and translation of RNAs via cis-elements within both coding and noncoding regions of messenger RNAs (mRNAs). A major component in this regulatory paradigm is the binding to RNA-stabilization and translational control elements by microRNAs (miRNAs), frequently in the 3(hermitian conjugative matrix) untranslated region of target mRNA. miRNAs are noncoding endogenously transcribed RNAs that undergo a well-characterized series of processing steps that generate short single-stranded (20-22. nt) RNA fragments that bind to complementary regions within a range of targets and inhibit translation, but primarily trigger mRNA degradation. This chapter will highlight selected advances in the role of miRNAs in liver disease including nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma and will briefly discuss the utility of miRNAs as biomarkers of liver injury and neoplasia, and how targeting or replenishing miRNAs may provide powerful and effective treatments for these diseases.

AB - Posttranscriptional regulation of gene expression is now recognized as an important contributor to disease pathogenesis, occurring by mechanisms that alter the function, stability, and translation of RNAs via cis-elements within both coding and noncoding regions of messenger RNAs (mRNAs). A major component in this regulatory paradigm is the binding to RNA-stabilization and translational control elements by microRNAs (miRNAs), frequently in the 3(hermitian conjugative matrix) untranslated region of target mRNA. miRNAs are noncoding endogenously transcribed RNAs that undergo a well-characterized series of processing steps that generate short single-stranded (20-22. nt) RNA fragments that bind to complementary regions within a range of targets and inhibit translation, but primarily trigger mRNA degradation. This chapter will highlight selected advances in the role of miRNAs in liver disease including nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma and will briefly discuss the utility of miRNAs as biomarkers of liver injury and neoplasia, and how targeting or replenishing miRNAs may provide powerful and effective treatments for these diseases.

KW - Bioinformatics

KW - Biomarker

KW - Cancer

KW - Hepatitis

KW - Hepatocellular

KW - Hepatoma

KW - Liver

KW - Liver injury

KW - Microarray

KW - MicroRNA

KW - Nonalcoholic fatty liver disease

KW - Nonalcoholic steatohepatitis

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=85009985928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009985928&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800553-8.00004-4

DO - 10.1016/B978-0-12-800553-8.00004-4

M3 - Chapter

AN - SCOPUS:85009985928

SN - 9780128005538

SP - 55

EP - 92

BT - Translating MicroRNAs to the Clinic

PB - Elsevier Inc.

ER -